The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...
Without U.S. funding, distribution from the warehouse, which stocks all U.S. government-donated HIV medicine to Kenya, has ...
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
14h
Medpage Today on MSNBroadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
12h
MedPage Today on MSNHundreds of Scientists, Doctors, Activists Rally for HIV Research FundingSAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results